Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.
Lancet
; 397(10279): 1057-1058, 2021 03 20.
Article
in English
| MEDLINE | ID: covidwho-1104346
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19
/
Antibodies, Viral
Type of study:
Observational study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Lancet
Year:
2021
Document Type:
Article
Affiliation country:
S0140-6736(21)00501-8
Similar
MEDLINE
...
LILACS
LIS